These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28992104)

  • 81. Excitatory Neurons Derived from Human-Induced Pluripotent Stem Cells Show Transcriptomic Differences in Alzheimer's Patients from Controls.
    Sagar R; Azoidis I; Zivko C; Xydia A; Oh ES; Rosenberg PB; Lyketsos CG; Mahairaki V; Avramopoulos D
    Cells; 2023 Aug; 12(15):. PubMed ID: 37566069
    [TBL] [Abstract][Full Text] [Related]  

  • 82. An Alzheimer's disease risk variant in TTC3 modifies the actin cytoskeleton organization and the PI3K-Akt signaling pathway in iPSC-derived forebrain neurons.
    Cukier HN; Duarte CL; Laverde-Paz MJ; Simon SA; Van Booven DJ; Miyares AT; Whitehead PL; Hamilton-Nelson KL; Adams LD; Carney RM; Cuccaro ML; Vance JM; Pericak-Vance MA; Griswold AJ; Dykxhoorn DM
    Neurobiol Aging; 2023 Nov; 131():182-195. PubMed ID: 37677864
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Wong MW; Braidy N; Poljak A; Pickford R; Thambisetty M; Sachdev PS
    Alzheimers Dement; 2017 Jul; 13(7):810-827. PubMed ID: 28242299
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A Review on MS-Based Blood Biomarkers for Alzheimer's Disease.
    Oeckl P; Otto M
    Neurol Ther; 2019 Dec; 8(Suppl 2):113-127. PubMed ID: 31833028
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.
    Devineni A; Tohme S; Kody MT; Cowley RA; Harris BT
    Am J Stem Cells; 2016; 5(3):99-106. PubMed ID: 27853631
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Accelerating stem cell trials for Alzheimer's disease.
    Hunsberger JG; Rao M; Kurtzberg J; Bulte JWM; Atala A; LaFerla FM; Greely HT; Sawa A; Gandy S; Schneider LS; Doraiswamy PM
    Lancet Neurol; 2016 Feb; 15(2):219-230. PubMed ID: 26704439
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Towards Personalized Intervention for Alzheimer's Disease.
    Peng X; Xing P; Li X; Qian Y; Song F; Bai Z; Han G; Lei H
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):289-297. PubMed ID: 27693548
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cell-line dependency in cerebral organoid induction: cautionary observations in Alzheimer's disease patient-derived induced pluripotent stem cells.
    Lee JH; Yoo G; Choi J; Park SH; Shin H; Prasad R; Lee Y; Ahn MR; Cho IJ; Sun W
    Mol Brain; 2022 May; 15(1):46. PubMed ID: 35578344
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry.
    Sjödin S; Öhrfelt A; Brinkmalm G; Zetterberg H; Blennow K; Brinkmalm A
    Clin Proteomics; 2016; 13():4. PubMed ID: 26924951
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Familial Alzheimer's disease modelling using induced pluripotent stem cell technology.
    Mohamet L; Miazga NJ; Ward CM
    World J Stem Cells; 2014 Apr; 6(2):239-47. PubMed ID: 24772250
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Proteomic Mapping of the Human Myelin Proteome.
    Guest PC
    Methods Mol Biol; 2022; 2343():191-202. PubMed ID: 34473323
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges.
    Israel MA; Goldstein LS
    Genome Med; 2011 Jul; 3(7):49. PubMed ID: 21867573
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Derivation of iPSC lines from two patients with familial Alzheimer's disease from India.
    Najar AH; Sneha KM; Ashok A; Babu S; Subramaniam AG; Kannan R; Viswanath B; Purushottam M; Varghese M; Parvez S; Panicker MM; Mukherjee O; Jain S
    Stem Cell Res; 2019 Jan; 34():101370. PubMed ID: 30605839
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Applications of induced pluripotent stem cells in studying the Alzheimer's disease].
    Ito D
    Nihon Rinsho; 2015 Jun; 73 Suppl 5():386-90. PubMed ID: 30458084
    [No Abstract]   [Full Text] [Related]  

  • 95. Establishment of PSEN1 mutant induced pluripotent stem cell (iPSC) line from an Alzheimer's disease (AD) female patient.
    Nemes C; Varga E; Táncos Z; Bock I; Francz B; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Jul; 17(1):69-71. PubMed ID: 27558604
    [No Abstract]   [Full Text] [Related]  

  • 96. Corrigendum to "Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD)" [Stem Cell Research 33(2018) 265-268].
    Wang Y; Zhang J; Lei Y; Zhao J
    Stem Cell Res; 2019 Apr; 36():101412. PubMed ID: 30826348
    [No Abstract]   [Full Text] [Related]  

  • 97. Exploratory biomarker assays: key assay parameters to evaluate in the face of evolving biomarker context-of-use.
    Thankamony SP; Zhang Y
    Bioanalysis; 2019 Dec; 11(23):2095-2097. PubMed ID: 31777269
    [No Abstract]   [Full Text] [Related]  

  • 98. Editorial:
    D'Amore A; Marchese M; Afshar-Saber W; Hameed MQ
    Front Neurosci; 2023; 17():1239577. PubMed ID: 37502680
    [No Abstract]   [Full Text] [Related]  

  • 99. The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis.
    Drummond E; Wisniewski T
    Neural Regen Res; 2017 Jun; 12(6):912-913. PubMed ID: 28761421
    [No Abstract]   [Full Text] [Related]  

  • 100. iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease.
    Kondo T; Imamura K; Funayama M; Tsukita K; Miyake M; Ohta A; Woltjen K; Nakagawa M; Asada T; Arai T; Kawakatsu S; Izumi Y; Kaji R; Iwata N; Inoue H
    Cell Rep; 2017 Nov; 21(8):2304-2312. PubMed ID: 29166618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.